Beam Therapeutics Inc. (BEAM) stock
BEAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3014% below fair value
$20.65−0.29 (-1.38%)
Close on Nov 17, 2026Market cap $2.13BP/E –Yield –
Beam Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Beam Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $156.04M, up 158.9% year over year. For fiscal 2025 it was $139.74M, up 120.0% from the year before. The highest annual figure on record is $377.71M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $139.74M | +120.0% |
| FY2024 | Dec 31, 2024 | $63.52M | -83.2% |
| FY2023 | Dec 31, 2023 | $377.71M | +520.0% |
| FY2022 | Dec 31, 2022 | $60.92M | +17.5% |
| FY2021 | Dec 31, 2021 | $51.84M | +215916.7% |
| FY2020 | Dec 31, 2020 | $24.00K | +33.3% |
| FY2019 | Dec 31, 2019 | $18.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $490.00K | -94.2% |
| Q1 FY2026 | Mar 31, 2026 | $31.74M | +324.9% |
| Q4 FY2025 | Dec 31, 2025 | $114.11M | +279.5% |
| Q3 FY2025 | Sep 30, 2025 | $9.70M | -32.0% |
| Q2 FY2025 | Jun 30, 2025 | $8.47M | -28.1% |
| Q1 FY2025 | Mar 31, 2025 | $7.47M | +0.8% |
| Q4 FY2024 | Dec 31, 2024 | $30.07M | -90.5% |
| Q3 FY2024 | Sep 30, 2024 | $14.27M | -17.0% |
| Q2 FY2024 | Jun 30, 2024 | $11.77M | -41.5% |
| Q1 FY2024 | Mar 31, 2024 | $7.41M | -69.4% |
| Q4 FY2023 | Dec 31, 2023 | $316.19M | +1478.0% |
| Q3 FY2023 | Sep 30, 2023 | $17.19M | +8.8% |
| Q2 FY2023 | Jun 30, 2023 | $20.12M | +20.8% |
| Q1 FY2023 | Mar 31, 2023 | $24.21M | +187.1% |
| Q4 FY2022 | Dec 31, 2022 | $20.04M | -60.8% |
| Q3 FY2022 | Sep 30, 2022 | $15.80M | +1970.6% |
| Q2 FY2022 | Jun 30, 2022 | $16.65M | +277433.3% |
| Q1 FY2022 | Mar 31, 2022 | $8.43M | +140433.3% |
| Q4 FY2021 | Dec 31, 2021 | $51.07M | +851050.0% |
| Q3 FY2021 | Sep 30, 2021 | $763.00K | +12616.7% |
| Q2 FY2021 | Jun 30, 2021 | $6.00K | 0.0% |
| Q1 FY2021 | Mar 31, 2021 | $6.00K | 0.0% |
| Q4 FY2020 | Dec 31, 2020 | $6.00K | 0.0% |
| Q3 FY2020 | Sep 30, 2020 | $6.00K | 0.0% |
| Q2 FY2020 | Jun 30, 2020 | $6.00K | 0.0% |
| Q1 FY2020 | Mar 31, 2020 | $6.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $6.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $6.00K | – |
| Q2 FY2019 | Jun 30, 2019 | $6.00K | – |
See a number that looks wrong?